Brooks Laboratories Ltd
Ticker: BROOKS
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
123.18
Market Cap
362.85
Debt/Equity
0.0773
ROE %
-12.181
PB
3.6984
Promoter %
52.620
Pledge %
0.000
1Y Rev Growth %
3.768
5Y Rev Growth %
NP Margin %
-11.949
NP Margin 5Y Avg %
-21.236
Trading Reference
1M Return %
-21.184
6M Return %
-12.265
1Y Return %
-16.204
% Away 52W High
61.439
% Away 52W Low
28.917
Daily Volume
57350
Investment Verdict
Risky
Score 49/100 · Position size: 6%
Higher volatility/weak areas. Consider only a small allocation if risk appetite is high.
Trading Verdict
Avoid
Score 14/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Brooks Laboratories Ltd is currently trading near a key support level, with recent volume indicating accumulation. If it breaks above the resistance level at 150, it could see a potential upside. However, if it falls below the support at 120, there could be significant downside risk.
Upside Probability: 20% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
G
Grand Continent Hotels Ltd
While Grand Continent Hotels Ltd shows potential in a recovering sector, inconsistencies in growth and profitability metrics warrant caution.
View details
L
Ludlow Jute & Specialities Ltd
Ludlow Jute & Specialities Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
F
Freshara Agro Exports Ltd
Freshara Agro Exports Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
F
Filatex Fashions Ltd
Filatex Fashions Ltd presents several risks with inconsistent growth and profitability metrics, alongside valuation concerns.
View details
M
Medicamen Biotech Ltd
Medicamen Biotech Ltd shows potential for growth but faces challenges in profitability and valuation. Caution is advised.
View details
P
Pavna Industries Ltd
Pavna Industries Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics.
View details
M
Moneyboxx Finance Ltd
Moneyboxx Finance Ltd shows potential for growth but faces several challenges that could impact its performance.
View details
R
RBM Infracon Ltd
RBM Infracon Ltd shows potential in a growing sector but faces significant risks and inconsistencies in financial performance.
View details
I
Infollion Research Services Ltd
Infollion Research Services Ltd shows potential but faces challenges in growth and profitability metrics. Caution is advised for investors.
View details
D
Dhanashree Electronics Ltd
Dhanashree Electronics Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
M
Mirza International Ltd
Mirza International Ltd presents a risky investment opportunity due to inconsistent growth and profitability metrics, alongside weak market sentiment.
View details
K
Kothari Products Ltd
Kothari Products Ltd shows potential but faces challenges in growth consistency and market sentiment.
View details
M
Mold-Tek Technologies Ltd
Mold-Tek Technologies Ltd shows potential for growth but faces challenges in profitability and valuation. Investors should be cautious.
View details
N
Nova Agritech Ltd
Nova Agritech Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks.
View details
O
Orient Ceratech Ltd
Orient Ceratech Ltd shows potential but faces significant challenges in growth and profitability metrics. Caution is advised.
View details
C
Career Point Edutech Ltd
Career Point Edutech Ltd shows potential in a growing sector but faces significant challenges in execution, profitability, and valuation, making it a risky investment.
View details
Business Overview
Brooks Laboratories Ltd is a leading pharmaceutical company in India, dedicated to providing high-quality healthcare solutions. Focused on research and development, the company specializes in manufacturing a wide range of pharmaceutical products, catering to both domestic and international markets. With a commitment to innovation and excellence, Brooks Laboratories plays a crucial role in enhancing health outcomes for patients and healthcare providers alike.
- Established player in the Indian pharmaceutical sector
- Focus on research and development
- Wide range of high-quality products
- Commitment to healthcare innovation
- Strong domestic and international presence
Investment Thesis
Brooks Laboratories Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. The company's strategic focus on innovation positions it well for sustained growth in the evolving market landscape.
- Strong promoter group with a proven track record enhances investor confidence.
- Expanding digital services segment poised for substantial growth.
- Attractive valuation metrics compared to industry peers make it a compelling buy.
- Robust financial performance and consistent revenue growth.
- Strategic initiatives aimed at enhancing operational efficiency and market reach.
Opportunity vs Risk
Opportunities
- Growing demand for healthcare products
- Expansion into new markets
- Strong R&D capabilities
- Strategic partnerships with hospitals
Risks ⚠️
- Regulatory changes impacting operations
- Intense competition in the sector
- Supply chain disruptions
- Market volatility affecting stock price
Peer Perspective
Brooks Laboratories Ltd trades at a discount to peers like Aarti Drugs and Granules India, primarily due to margin volatility; a stable margin performance could trigger a rerating, aligning it closer to its competitors.
Future Outlook
Brooks Laboratories Ltd is poised for growth, driven by innovative product development and expanding market reach. Successful execution of cost control measures will be crucial to maximize profitability and sustain momentum.
AI FAQs for Retail Users
- Q: What does Brooks Laboratories Ltd do?A: Brooks Laboratories Ltd specializes in pharmaceutical manufacturing and offers contract research services.
- Q: Is Brooks Laboratories Ltd a good investment?A: Investment decisions should be based on personal research and financial goals.
- Q: What are the risks of investing in this stock?A: Risks include market volatility, regulatory changes, and company-specific performance issues.
- Q: How can I buy shares of Brooks Laboratories Ltd?A: You can purchase shares through a registered stockbroker or online trading platform.
- Q: What is the company's growth outlook?A: Growth outlook depends on market conditions, company strategy, and industry trends.
📊 Stock Investment Checklist (100 Points)
Brooks Laboratories Ltd • Updated: 2025-09-16 20:04:56
-
10BusinessHighThe pharmaceutical sector is growing, but competition is intense.
-
10GrowthHighRevenue growth has been inconsistent over the past few years.
-
10ProfitabilityHighROE and ROCE are moderate, with cash flow issues noted.
-
8ValuationHighValuation metrics are above industry averages.
-
7BalanceHighDebt levels are manageable, but liquidity is a concern.
-
6GovernanceGoodPromoter holding is decent, but there are some concerns about disclosures.
-
5DriversGoodGrowth catalysts are limited, with execution risks present.
-
5TechnicalsGoodMarket sentiment is neutral, with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
Brooks Laboratories Ltd shows potential in a growing sector, but faces challenges in growth consistency and profitability metrics.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100